DK0773022T3 - Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre - Google Patents

Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre

Info

Publication number
DK0773022T3
DK0773022T3 DK96117235T DK96117235T DK0773022T3 DK 0773022 T3 DK0773022 T3 DK 0773022T3 DK 96117235 T DK96117235 T DK 96117235T DK 96117235 T DK96117235 T DK 96117235T DK 0773022 T3 DK0773022 T3 DK 0773022T3
Authority
DK
Denmark
Prior art keywords
pantothenol
pantothenic acid
sympathomimetics
treatment
pharmaceutical composition
Prior art date
Application number
DK96117235T
Other languages
Danish (da)
English (en)
Inventor
Rainer Dr Greve
Harald Dr Greve
Original Assignee
Klosterfrau Mcm Vetrieb Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7777112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0773022(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1995141919 external-priority patent/DE19541919C2/de
Application filed by Klosterfrau Mcm Vetrieb Gmbh filed Critical Klosterfrau Mcm Vetrieb Gmbh
Application granted granted Critical
Publication of DK0773022T3 publication Critical patent/DK0773022T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK96117235T 1995-11-10 1996-10-27 Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre DK0773022T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1995141919 DE19541919C2 (de) 1995-11-10 1995-11-10 Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden

Publications (1)

Publication Number Publication Date
DK0773022T3 true DK0773022T3 (da) 2002-05-13

Family

ID=7777112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96117235T DK0773022T3 (da) 1995-11-10 1996-10-27 Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre

Country Status (8)

Country Link
US (1) US5801199A (pt)
EP (1) EP0773022B3 (pt)
JP (1) JP3597333B2 (pt)
AT (1) ATE212837T1 (pt)
DE (2) DE19549421C2 (pt)
DK (1) DK0773022T3 (pt)
ES (1) ES2171590T7 (pt)
PT (1) PT773022E (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053775A1 (en) * 1998-01-30 2001-12-20 Matthias Seidel Nasal solutions
PT1051155E (pt) * 1998-01-30 2002-10-31 Novartis Consumer Health Sa Solucoes nasais
BR0011950A (pt) * 1999-06-22 2002-03-12 Boehringer Ingelheim Int Solução de xilometazolina e oximetazolina estável
DE10161110A1 (de) † 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
NZ537186A (en) * 2002-06-20 2006-10-27 Novartis Consumer Health S Nasal compositions comprising a mucopolysaccharide and propylene glycol
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
DE20318634U1 (de) * 2003-11-13 2004-02-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
US7812049B2 (en) * 2004-01-22 2010-10-12 Vicept Therapeutics, Inc. Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists
US8304402B2 (en) * 2005-05-05 2012-11-06 Binyarco, Llc Composition and method for treating nosebleeds
DE102007052380A1 (de) 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
DE102008036725B4 (de) * 2008-08-07 2021-01-28 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung für die nasale Applikation
CN103796652A (zh) * 2011-07-14 2014-05-14 阿勒根公司 羟甲唑啉的凝胶组合物及使用方法
DE102012005452A1 (de) * 2011-12-30 2013-07-04 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
DE202012005650U1 (de) * 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis
BR112017002356A2 (pt) * 2014-08-08 2017-11-28 Shanghai Hightide Biopharmaceutical Ltd composições de formulação líquida, dispositivos de entrega de medicamento e métodos para preparação e uso dos mesmos
DE202014105553U1 (de) 2014-08-18 2015-08-20 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige Zusammensetzung für die nasale Applikation
WO2016102984A1 (en) 2014-12-24 2016-06-30 Jadran - Galenski Laboratorij D.D. A nasal composition containing sea water as stability-improving excipient
DE202015104410U1 (de) 2015-07-06 2016-07-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die Behandlung von Rhinitis
DE102015115107A1 (de) 2015-09-01 2017-03-02 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Cineolhaltige wässrige Zusammensetzung für die nasale Applikation
DE102017117987A1 (de) 2017-07-31 2019-01-31 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
EP3664818B1 (en) * 2017-08-10 2023-11-29 Elixir Ilaç Arastirma Ve Gelistirme A.S. Nasal decongestant compositions comprising menthol, dexpanthenol and sodium hyaluronate
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146570A1 (de) * 1980-12-06 1982-07-08 Dr.med. Dietrich Ibiza Reichert Mittel zur bekaempfung des schnarchens
DE3317530A1 (de) * 1983-05-13 1984-11-15 Dietrich Dr.med. Sta. Eulalia Ibiza Reichert Antischnarchmittel
US4665069A (en) * 1985-04-02 1987-05-12 Barnett Rosenberg Analgesic composition and method of relieving pain
DE3832401A1 (de) * 1988-09-23 1990-03-29 Cassella Ag Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute
GB2252905B (en) * 1991-02-11 1995-05-10 Leung Lit Hung An agent for correcting a deficiency of androgenic steroids
US5508282C1 (en) * 1993-05-17 2001-01-23 Tulin Silver Jeffrey Composition and method for treating acute or chronic rhinosinusitis

Also Published As

Publication number Publication date
EP0773022B3 (de) 2013-02-06
DE59608698D1 (de) 2002-03-21
PT773022E (pt) 2002-06-28
JPH09176013A (ja) 1997-07-08
DE19549421C2 (de) 1999-11-18
ES2171590T3 (es) 2002-09-16
EP0773022A2 (de) 1997-05-14
EP0773022B1 (de) 2002-02-06
ATE212837T1 (de) 2002-02-15
US5801199A (en) 1998-09-01
DE19549421A1 (de) 1997-05-15
JP3597333B2 (ja) 2004-12-08
ES2171590T7 (es) 2013-05-16
EP0773022A3 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
DK0773022T3 (da) Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre
DK0787489T3 (da) Sammensætning, der indeholder propionyl-L-carnitin og hydroxycitronsyre eller pantothensyre
NO20002172L (no) FremgangsmÕte for behandling av hyperkolesterolemi med usubstituert polydiallylamin
NO914092L (no) Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace
DK0650961T3 (da) Substituerede heterocykliske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler.
NO944161D0 (no) Substituerte heterocykliske karboksylsyreamidestere, deres fremstilling og deres anvendelse som legemiddel
BR9810137A (pt) Composto, composição farmacêutica e método de tratamento ou prevenção de uma desordem tromoboembólica
DK0596838T3 (da) Estere af L-carnitin og alkanoyl-L-carnitiner med glycolsyre eller estere deraf og farmaceutiske præparater indeholdende samme til behandling af dermatoser
DK0603649T3 (da) Substituerede 4-phenyl-pyridoner og 4-phenyl-2-alkoxypyridiner som HMG-CoA-reduktase-inhibitorer
DK0699439T3 (da) Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DK1140186T3 (da) Kombinationer af cholesterylestertransferproteinhæmmere og derivater af fibrinsyre til hjertekar indikationer
DK605589A (da) Anvendelse af aminobenzocycloalkaner eller syreadditionssalte deraf til fremstilling af et farmaceutikum, saaledes fremstillet praeparat og dettes anvendelse
AU670491B2 (en) Pharmaceutical for the treatment of skin disorders
NO923393L (no) Fremgangsmaate for inhibering av korrosjon i broenner som syrebehandle
DE69415457D1 (de) Tertiärbutylesterderivate der 4,4-bis (4'Hydroxyphenyl)pentansäure und diese enthaltende positive Photoresiste
DK0590272T3 (da) 17beta-aryl og 17beta-heterocyclyl-5beta,14beta-androstanderivater med en virkning på det cardiovaskulære system, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende disse
NO980994D0 (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmasöytika
IT1282289B1 (it) 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare,
DK0576913T3 (da) Digitoxigenin og dihydrodigitoxigenin 3 beta-derivater samt farmaceutiske præparater indeholdende sådanne til behandling af hypertension
AR015371A1 (es) Uso de un derivado de 7alfa-etinil-estrano y un metodo para inhibir el proceso de la ateroesclerosis que comprende administrar a un mamifero dicho derivado
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno
NO179172C (no) Nytt arylpiperidin-derivat og farmasöytiske blandinger som inneholder det